Follow-Up Study of Breast Cancer and Multiple Myeloma Subjects Previously Enrolled in Retroviral Gene Transfer Studies
This Protocol aims to provide long-term follow-up of breast cancer and multiple myeloma
subjects previously receiving autologous primitive marrow and blood hematopoietic cells
exposed to gene transfer retroviral vectors on the following protocols: MB 294 (92-C-0161;
T-92-0018), MB 310 (93-C-0208; T-92-0192), MB 361 (96-C-0007; T-95-0096) or (92-H-0057;
T-92-0139) at the National Cancer Institute and the National Heart, Lung, and Blood
Institute. Subjects will undergo an annual health history and annual complete blood counts
will be performed. Blood samples will also be collected annually (either locally or
off-site by the subjects' personal physicians) for testing for presence of the gene transfer
vector and vector integration sites.
Ronald E Gress, M.D.
National Cancer Institute (NCI)
United States: Federal Government
|National Institutes of Health Clinical Center, 9000 Rockville Pike||Bethesda, Maryland 20892|